Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 30, 2005Journal of Clinical Oncology

Randomized Controlled Trial of Tamoxifen in Advanced Hepatocellular Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJean‐Claude BarbareUniLaSalle Amiens (ESIEE-Amiens)OBOlivier BouchéCentre Hospitalier Universitaire de ReimsFBFranck BonnetainMethodology and Quality of Life Unit in Oncology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barbare et al. (2005) studied this question.

synapsesocial.com/papers/6aaf6e5adebf0b2b005d2e0ehttps://doi.org/10.1200/jco.2005.05.470
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The effect of estrogen and tamoxifen on hepatocyte proliferation in Vivo and in Vitro1989 · 129 citations
  2. 2Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors2004 · 875 citations
  3. 3Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial2001 · 355 citations
  4. 4Transection of the oesophagus for bleeding oesophageal varices1973 · 8,035 citations
  5. 5Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial2002 · 53 citations